Celesio AG (CLSGn.DE)
16.80EUR
7:19am EDT
€-0.22 (-1.29%)
€15.80
€17.00
€17.06
€16.80
69,408
602,517
€18.00
€12.81
About
Overall
| Beta: | 0.84 |
| Market Cap (Mil.): | €2,894.25 |
| Shares Outstanding (Mil.): | 170.10 |
| Dividend: | 0.30 |
| Yield (%): | 1.76 |
Financials
| CLSGn.DE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 29.26 | 17.12 | 39.77 |
| EPS (TTM): | 0.58 | -- | -- |
| ROI: | 2.33 | 9.99 | 66.51 |
| ROE: | 4.18 | 11.32 | 72.84 |
BRIEF-Celesio shares post heavy losses after CEO sacked by owner Haniel
FRANKFURT, July 4 - Celesio AG : * Shares open down 4.3 percent after majority owner haniel sacks CEO
Celesio fires CEO Pinger after management dispute
FRANKFURT - The supervisory board of Celesio has sacked the German drugs distributor's chief executive, Markus Pinger, with immediate effect after a falling out with the head of parent company Franz Haniel & Cie .
UPDATE 2-Celesio fires CEO Pinger after management dispute
* Sources say tension grew after talks with U.S. investors
Celesio fires CEO Pinger
FRANKFURT, July 3 - The supervisory board of Celesio has sacked the German drugs distributor's chief executive, Markus Pinger, with immediate effect, it said on Wednesday.
Exclusive: U.S. drug firms vie to take stake in Celesio - sources
FRANKFURT - Two U.S. drugs distribution groups McKesson Corp and Cardinal Health Inc are both in talks to possibly take a stake in German drugs company Celesio , two industry sources familiar with the situation said.
Haniel denies in talks with CVS to sell Celesio stake
DUESSELDORF, Germany - Diversified holding company Franz Haniel & Cie said on Wednesday it was not in talks with U.S. drugstore chain CVS to sell majority control over German drug distributor Celesio .
UPDATE 1-Haniel denies in talks with CVS to sell Celesio stake
* CVS prepared to pay Celesio 2 bln eur for stake -magazine
Haniel says not in talks with CVS to sell Celesio stake
DUESSELDORF, Germany, June 19 - Diversified holding company Franz Haniel & Cie on Wednesday said it was not in talks with U.S. group CVS to sell its 50.01 percent stake in German drug distributor Celesio, denying an earlier press report.
Celesio Q1 core profit drops on competition in home market
FRANKFURT, May 14 - Celesio, Europe's largest drugs distributor, posted a steeper-than-expected decline in core earnings as harsh competition prompted a slide in prices charged to German pharmacies.
Haniel says has no plans to cut Celesio stake
FRANKFURT, May 6 - Diversified holding company Franz Haniel & Cie. said it has no plans to further reduce its stake in German drugs distributor Celesio, rebuffing a media report.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Thomson Reuters StreetEvents
|
$75.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

